Literature DB >> 9203678

Differential production of and migratory response to beta chemokines by human microglia and astrocytes.

P K Peterson1, S Hu, J Salak-Johnson, T W Molitor, C C Chao.   

Abstract

Little is known about the participation of beta chemokines in inflammatory processes within the central nervous system. The release of three of these peptides (macrophage inflammatory protein [MIP]-1alpha, MIP-1beta, and monocyte chemoattractant protein-1) from human fetal microglial cell and astrocyte cultures was assessed following stimulation by lipopolysaccharide, interleukin-1beta, and tumor necrosis factor-alpha. Although striking differences were found between these two types of glial cells in their responsiveness to lipopolysaccharide and cytokines, both microglia and astrocytes produced all three beta chemokines. Only microglial cells, however, demonstrated an increased migratory response to the beta chemokines. The results of this in vitro study suggest that beta chemokines may play an important role in the trafficking of mononuclear phagocytes within the brain.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9203678     DOI: 10.1093/infdis/175.2.478

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  49 in total

1.  Robust expression of TNF-alpha, IL-1beta, RANTES, and IP-10 by human microglial cells during nonproductive infection with herpes simplex virus.

Authors:  J R Lokensgard; S Hu; W Sheng; M vanOijen; D Cox; M C Cheeran; P K Peterson
Journal:  J Neurovirol       Date:  2001-06       Impact factor: 2.643

2.  Cytomegalovirus induces cytokine and chemokine production differentially in microglia and astrocytes: antiviral implications.

Authors:  M C Cheeran; S Hu; S L Yager; G Gekker; P K Peterson; J R Lokensgard
Journal:  J Neurovirol       Date:  2001-04       Impact factor: 2.643

3.  Changes in the NMR metabolic profile of human microglial cells exposed to lipopolysaccharide or morphine.

Authors:  Issam El Ghazi; Wen S Sheng; Shuxian Hu; Brian G Reilly; James R Lokensgard; R Bryan Rock; Phillip K Peterson; George L Wilcox; Ian M Armitage
Journal:  J Neuroimmune Pharmacol       Date:  2010-03-25       Impact factor: 4.147

Review 4.  Role of microglia in central nervous system infections.

Authors:  R Bryan Rock; Genya Gekker; Shuxian Hu; Wen S Sheng; Maxim Cheeran; James R Lokensgard; Phillip K Peterson
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

5.  CCR2 mediates increases in glial activation caused by exposure to HIV-1 Tat and opiates.

Authors:  Nazira El-Hage; Guanghan Wu; Jayakrishna Ambati; Annadora J Bruce-Keller; Pamela E Knapp; Kurt F Hauser
Journal:  J Neuroimmunol       Date:  2006-07-10       Impact factor: 3.478

6.  Interferon lambda inhibits herpes simplex virus type I infection of human astrocytes and neurons.

Authors:  Jieliang Li; Shuxian Hu; Lin Zhou; Li Ye; Xu Wang; Jie Ho; Wenzhe Ho
Journal:  Glia       Date:  2010-09-27       Impact factor: 7.452

7.  HIV-1 tat protein induces a migratory phenotype in human fetal microglia by a CCL2 (MCP-1)-dependent mechanism: possible role in NeuroAIDS.

Authors:  Eliseo A Eugenin; Gawain Dyer; Tina M Calderon; Joan W Berman
Journal:  Glia       Date:  2005-03       Impact factor: 7.452

8.  Roles of the DOCK-D family proteins in a mouse model of neuroinflammation.

Authors:  Kazuhiko Namekata; Xiaoli Guo; Atsuko Kimura; Yuriko Azuchi; Yuta Kitamura; Chikako Harada; Takayuki Harada
Journal:  J Biol Chem       Date:  2020-04-02       Impact factor: 5.157

Review 9.  Role of chemokines in CNS health and pathology: a focus on the CCL2/CCR2 and CXCL8/CXCR2 networks.

Authors:  Bridgette D Semple; Thomas Kossmann; Maria Cristina Morganti-Kossmann
Journal:  J Cereb Blood Flow Metab       Date:  2009-11-11       Impact factor: 6.200

10.  APOE genotype-dependent modulation of astrocyte chemokine CCL3 production.

Authors:  Eiron Cudaback; Yue Yang; Thomas J Montine; C Dirk Keene
Journal:  Glia       Date:  2014-08-04       Impact factor: 7.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.